Tower Research Capital LLC (Trc) Athersys, Inc Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.18 - $0.86 $3,186 - $15,222
-17,700 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$0.6 - $1.06 $3,474 - $6,137
5,790 Added 48.61%
17,700 $11,000
Q4 2021

Feb 14, 2022
SELL
$0.85 - $1.4 $3,534 - $5,821
-4,158 Reduced 25.88%
11,910 $11,000
Q3 2021

Nov 15, 2021
SELL
$1.33 - $1.77 $36,443 - $48,499
-27,401 Reduced 63.04%
16,068 $22,000
Q2 2021

Aug 16, 2021
BUY
$1.41 - $1.94 $28,917 - $39,787
20,509 Added 89.32%
43,469 $63,000
Q1 2021

May 17, 2021
SELL
$1.61 - $2.77 $59,431 - $102,251
-36,914 Reduced 61.65%
22,960 $41,000
Q4 2020

Feb 16, 2021
SELL
$1.55 - $2.24 $517,362 - $747,671
-333,782 Reduced 84.79%
59,874 $105,000
Q3 2020

Nov 16, 2020
BUY
$1.91 - $3.08 $550,607 - $887,890
288,276 Added 273.56%
393,656 $768,000
Q2 2020

Aug 13, 2020
BUY
$1.97 - $3.98 $207,598 - $419,412
105,380 New
105,380 $291,000
Q1 2020

May 15, 2020
SELL
$1.17 - $3.0 $55,556 - $142,452
-47,484 Closed
0 $0
Q4 2019

Feb 07, 2020
BUY
$1.16 - $1.42 $35,540 - $43,505
30,638 Added 181.87%
47,484 $58,000
Q3 2019

Nov 05, 2019
BUY
$1.21 - $1.65 $20,383 - $27,795
16,846 New
16,846 $23,000
Q2 2019

Aug 13, 2019
SELL
$1.39 - $2.03 $6,640 - $9,697
-4,777 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$1.39 - $1.71 $6,036 - $7,426
4,343 Added 1000.69%
4,777 $7,000
Q4 2018

Feb 14, 2019
SELL
$1.41 - $2.16 $87 - $133
-62 Reduced 12.5%
434 $1,000
Q3 2018

Nov 13, 2018
BUY
$1.86 - $2.18 $922 - $1,081
496 New
496 $1,000
Q1 2018

May 15, 2018
SELL
$1.34 - $2.03 $6,158 - $9,329
-4,596 Closed
0 $0
Q4 2017

Feb 09, 2018
SELL
$1.65 - $2.45 $18,087 - $26,856
-10,962 Reduced 70.46%
4,596 $9,000
Q3 2017

Nov 14, 2017
BUY
$1.5 - $2.55 $23,337 - $39,672
15,558
15,558 $32,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email